IMMUCELL CORP. DL-,10IMMUCELL CORP. DL-,10IMMUCELL CORP. DL-,10

IMMUCELL CORP. DL-,10

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪32.76 M‬EUR
−0.46EUR
‪−5.23 M‬EUR
‪15.83 M‬EUR
‪5.62 M‬
Beta (1Y)
0.43

About ImmuCell Corporation

CEO
Michael F. Brigham
Headquarters
Portland
Employees (FY)
79
Founded
1982
FIGI
BBG000GS83P8
ImmuCell Corp. engages in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kits, and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange IMMUCELL CORP. DL-,10 stocks are traded under the ticker IUL.
IUL reached its all-time high on Jul 31, 2015 with the price of 10.04 EUR, and its all-time low was 3.44 EUR and was reached on Mar 16, 2020. View more price dynamics on IUL chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track IMMUCELL CORP. DL-,10 financials in yearly and quarterly reports right on TradingView.
IMMUCELL CORP. DL-,10 is going to release the next earnings report on Aug 8, 2024. Keep track of upcoming events with our Earnings Calendar.
IUL net income for the last quarter is ‪−405.81 K‬ EUR, while the quarter before that showed ‪−1.03 M‬ EUR of net income which accounts for 60.71% change. Track more IMMUCELL CORP. DL-,10 financial stats to get the full picture.
No, IUL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 26, 2024, the company has 79.00 employees. See our rating of the largest employees — is IMMUCELL CORP. DL-,10 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IMMUCELL CORP. DL-,10 EBITDA is ‪−958.13 K‬ EUR, and current EBITDA margin is −17.35%. See more stats in IMMUCELL CORP. DL-,10 financial statements.
Like other stocks, IUL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMMUCELL CORP. DL-,10 stock right from TradingView charts — choose your broker and connect to your account.